Minirin Information
Minirin is a prescription drug, available for use as Tablet, Spray. It is primarily used for the treatment of Bedwetting, Diabetes Insipidus. Minirin also has some secondary and off-label uses. These are listed below.
The correct dosage of Minirin depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Apart from the aforementioned side effects, Minirin can also lead to other problems, which have been listed below. Normally, these side effects of Minirin are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Minirin's effect is Unknown during pregnancy and Unknown for lactating mothers. Further, the section on Minirin related warnings talks about Minirin's effects on the liver, heart and kidney.
Some other conditions that can be affected by Minirin are listed in the contraindications section below.
Drug reaction of Minirin with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Minirin is considered safe while driving, and is addictive.
Minirin Benefits & Uses
Minirin is used to treat the following -
Other Benefits
Minirin Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Minirin Side Effects
Based on research, the following side effects have been observed when Minirin is used -
Moderate
- Hypertension
- Tachycardia
Mild
- Headache
- Stomach ache (Read More - Home remedies for stomach pain)
- Abdominal cramp
- Rhinitis
Minirin Related Warnings
-
Is the use of Minirin safe for pregnant women?
Side effects of Minirin during pregnancy are not known because scientific research on this topic hasn't been done.
Unknown -
Is the use of Minirin safe during breastfeeding?
Information about safety of Minirin for women who are breastfeeding is not available since scientific research on this is yet to be done.
Unknown -
What is the effect of Minirin on the Kidneys?
Using Minirin does not have any harmful effects on kidneys.
Safe -
What is the effect of Minirin on the Liver?
Very few cases of side effects of Minirin on the liver have been reported.
Mild -
What is the effect of Minirin on the Heart?
You may experience side effects on your heart after taking Minirin. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Moderate
Severe Interaction of Minirin with Other Drugs
Minirin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Minirin Contraindications
If you are suffering from any of the following diseases, you should not take Minirin unless your doctor advises you to do so -
- Hemophilia A
- Kidney Disease
- Infections
- Heart Disease
Frequently asked Questions about Minirin
-
Is this Minirin habit forming or addictive?
Minirin is not addictive in nature.
No -
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Minirin as it does not make you drowsy.
Safe -
Is it safe?
Minirin should be used only after doctor's advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Minirin cannot treat any kind of mental disorder.
No
Minirin Interactions with Food and Alcohol
-
Interaction between Food and Minirin
There is no information on the effects of taking Minirin with food, because this topic has not been scientifically researched yet.
Unknown -
Interaction between Alcohol and Minirin
Information about the interaction of Minirin and alcohol is not currently available because this topic has not been researched yet.
Unknown
See all substitutes for Minirin
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 413-415
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 596-597
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ddavp® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Noctiva™ (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nocdurna® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stimate® (desmopressin acetate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 413-415
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 596-597
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ddavp® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Noctiva™ (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nocdurna® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stimate® (desmopressin acetate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 413-415
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 596-597
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ddavp® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Noctiva™ (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nocdurna® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stimate® (desmopressin acetate)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 413-415
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 596-597
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ddavp® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Noctiva™ (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nocdurna® (desmopressin acetate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Stimate® (desmopressin acetate)
